Tony Hunter Celebration
When: February 21, 2025
Where: Salk Institute
Schedule:
| 9:00 a.m. | Registration begins |
| 10:00 a.m. | Opening remarks – Gerald Joyce, President, Salk Institute |
| 10:10 a.m. | Lew Cantley, Harvard Medical School The discovery of PI-3 kinase and how tyrosine phosphorylation leads to PI-3 kinase signaling, and the development of PI-3 kinase inhibitors as cancer drugs |
| 10:50 a.m. | Susan Taylor, UC San Diego How elucidating the structure of the protein kinase A catalytic domain has enabled the development of selective kinase inhibitors |
| 11:30 a.m. | Sara Courtneidge, Oregon Health and Science University From the discovery that SRC is a membrane protein to its role in cell invasion through activating invadosome function |
| 12:10 p.m. | Martine Roussel, St. Jude Children’s Research Hospital From Erb, Mac and Myb to CDK inhibitors and medulloblastoma mechanisms and new targeted therapies |
| 1:00 p.m. | Lunch |
| 2:00 p.m. | Jon Cooper, Fred Hutchinson Cancer Center From using 2D gels to identify tyrosine kinase substrates to studies of how CAS tyrosine phosphorylation regulates focal adhesion assembly |
| 2:35 p.m. | Ruth Palmer, University of Gothenburg What model organisms have taught us about the role of the ALK receptor tyrosine kinase in human neuroblastoma |
| 3:10 p.m. | John Brognard, Hunter Lab Alumni Tracking down the elusive dark kinome to identify new cancer drug targets |
| 3:45 p.m. | Sean Yamada-Hunter, Stanford University From purifying antibodies in the Hunter lab to becoming a protein engineer who develops novel CAR T cells |
| 4:05 p.m. | Reuben Shaw, Cancer Center Director, Salk Institute The 50-year history of the Salk Cancer Center and the discoveries its scientists have made that have led to new cancer drugs |
| 4:40 p.m. | Tony Hunter, Salk Institute Perspectives on the science that Salk has enabled me to do over the past 50 years and where it has led |
| 5:15 p.m. | Closing remarks – Jan Karlseder, Chief Science Officer, Salk Institute |
| 5:30 p.m. | Reception |
Registration is now closed.